0000950170-24-007962.txt : 20240126
0000950170-24-007962.hdr.sgml : 20240126
20240126163007
ACCESSION NUMBER: 0000950170-24-007962
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240124
FILED AS OF DATE: 20240126
DATE AS OF CHANGE: 20240126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roche Corleen M.
CENTRAL INDEX KEY: 0001857905
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41925
FILM NUMBER: 24568312
MAIL ADDRESS:
STREET 1: 665 STOCKTON DRIVE, SUITE 300
STREET 2: C/O IMMUNOME, INC.
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CG Oncology, Inc.
CENTRAL INDEX KEY: 0001991792
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 371611499
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 SPECTRUM CENTER DRIVE
STREET 2: SUITE 2040
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 419-6203
MAIL ADDRESS:
STREET 1: 400 SPECTRUM CENTER DRIVE
STREET 2: SUITE 2040
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
ownership.xml
4
X0508
4
2024-01-24
0001991792
CG Oncology, Inc.
CGON
0001857905
Roche Corleen M.
C/O CG ONCOLOGY, INC.
400 SPECTRUM CENTER DRIVE, SUITE 2040
IRVINE
CA
92618
false
true
false
false
CFO & Secretary
false
Stock Option
19.00
2024-01-24
4
A
false
492920
0
A
2034-01-10
Common Stock
492920
492920
D
The stock option vests as to 25% of the underlying shares on January 16, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.
/s/ Corleen Roche
2024-01-26